Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study

Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study

Bibliographic Details
Main Authors: Stein, Alexander, Kapp, Kerstin, Scheithauer, Werner, Salazar, Ramon, Ducreux, Michel, Waddell, Tom, Arnold, Dirk, Tournigand, Christophe, Sobrero, Alberto, Van Cutsem, Eric, Schmidt, Manuel, Cunningham, David
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645257/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645257/

Similar Items